Chronic respiratory diseases including bronchial asthma.
Conditions
Interventions
Patients diagnosed with chronic respiratory diseases, including bronchial asthma, will be assigned to two groups: Group A (standard inhalation method) and Group B (Hoo inhalation) after the target med
Sponsors
Nihon Medical University Respiratory Care Clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1 Those who have been diagnosed with chronic respiratory diseases, including bronchial asthma, and have started the target drug 2 FeNO 22ppb or more 3 18 years and older 4 Those who have obtained consent by explaining this research using explanatory document
Exclusion criteria
Exclusion criteria: 1.Those judged to have insufficient understanding of inhalation. 2.Those judged to have difficulty mastering inhalation techniques. 3.Those deemed inappropriate for participation in this study by the principal investigator or co-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| fraction of exhaled nitric oxide(FeNO) start of research, measurement taken 4 weeks after the start of research. | — |
Secondary
| Measure | Time frame |
|---|---|
| asthma control test start of research, measurement taken 4 weeks after the start of research hoarseness questionnaire measurement taken 4 weeks after the start of research. | — |
Countries
Japan
Contacts
Public ContactSatomi Yoshikawa
Nippon medical school hospital pharmacy Department
Outcome results
None listed